[PDF][PDF] Diffuse large B-cell lymphoma research in Malaysia: A review
Lymphomas are prevalent worldwide and a common malignancy reported in Malaysia.
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of B-cell lymphomas …
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of B-cell lymphomas …
FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway
Y Zhang, CP Wang, XX Ding, N Wang… - Asian Pacific Journal …, 2014 - koreascience.kr
Chemotherapy is the primary therapy for malignant lymphoma (ML). However, the clinical
outcome is still far from satisfactory. Consequently, an understanding of the mechanism of …
outcome is still far from satisfactory. Consequently, an understanding of the mechanism of …
Quality of life amongst lymphoma survivors in a developing country
DLC Ng, YC Leong, GG Gan - Supportive care in cancer, 2016 - Springer
Purpose The survival for patients with lymphoma has improved over the past decades with
the introduction of novel agents. Quality of life of these survivors is now being studied with …
the introduction of novel agents. Quality of life of these survivors is now being studied with …
Unmet needs in the first-line treatment of diffuse large B-cell lymphoma: Expert recommendations from the Asia-Pacific region with a focus on the challenging subtypes
D Tan, JY Chan, K Wudhikarn, RSM Wong… - … Myeloma and Leukemia, 2024 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin
lymphoma, accounting for around 30–60% of all cases. The management of DLBCL in Asia …
lymphoma, accounting for around 30–60% of all cases. The management of DLBCL in Asia …